Lauren Berkowitz

Hi. I'm Lauren Berkowitz.

My ambition: Help a billion people get ahead of their genes.

As someone who inherited a BRCA1 mutation, I'm both the strategist and the use case.

Genomics is making it possible to identify serious health risks long before disease appears. But healthcare systems aren't yet set up to act on that knowledge, and people aren't prepared to live with it.

I've built my career around successive technology transformations, from digital media to commercial AI and now genomic healthcare. I ran digital media businesses at Sony and Universal, led AI product development and launches at IBM, and served as Chief of Staff to the Head of AI at Bridgewater and to the CEO of Bessor Pharma, a cancer R&D company.

My focus now is on helping lead the next shift in healthcare, turning genomic knowledge into meaningful action at population scale.

Turning Complex Science Into Real-World Impact

My work addresses the institutional and human challenges of genomic medicine through strategic intelligence and science communication.

01

Strategic Intelligence & Systems Design

A system connecting discoveries, decisions, and patients.

Genetic medicine is advancing rapidly, but the ecosystem connecting research, institutions, industry, and patients remains fragmented. Important connections and opportunities can be missed, slowing scientific progress and delaying the translation of discoveries into care.

Presented at Weill Cornell Medicine's Innovations in Cancer Genetics Symposium, October 2026.

02

Science Communication & Patient Understanding

Making complex science understandable, personal, and actionable.

Genetic medicine can identify serious inherited risks long before symptoms appear. But knowing your risk and knowing what to do with that knowledge are very different things. The science is complex, the choices are consequential, and the emotional experience is often overlooked.

Partnership

Developed in partnership with the Institute for Advanced Enterprise AI, part of the Center for Global Enterprise.

“More than an information resource, this book is like a friend who understands.”

Sue FriedmanFounder and Executive Director, FORCE

“Nowheresville is at once easy to grasp and philosophical, two qualities of the best science writing.”

Roxanne KhamsiScience journalist, contributing writer at The Atlantic, and author of Beyond Inheritance

Selected Experience

Technology, AI & Transformation

Led digital businesses, AI product innovation, commercialization, and large-scale organizational transformation.

Sony · Universal · IBM · Bridgewater · WD

Healthcare Innovation & Research

Applied AI and technology to healthcare research, drug discovery, accessibility, cancer R&D, and patient navigation.

IBM · Elemental Cognition · Bessor Pharma · Argand (with Dana-Farber) · One Llama Labs

Education & Affiliations

Education

JD/MBA, Suffolk University · BS, Boston University · Genetics Certificate, Harvard Medical School

Law school thesis on the Human Genome Project.

Advisory & Recognition

FORCE Leadership Advisory Board

Nowheresville featured at the Weill Cornell Medicine Innovations in Cancer Genetics Symposium 2026 and the PRECEDE Consortium global annual event.

Ideas & Writing

On technology, genetics, and being human.

I write about the changes reshaping medicine, the questions technology raises, and what happens when scientific advances become deeply personal. Selected essays from Ctrl Alt Human.

Newsletter

Join readers getting essays on AI, genomics, and the human side of transformation.